🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pilot study of the feasibility of an innovative multimodal treatment combin...
Status
Recruiting
Location
Institut Coeur-Poumon, CHU
Start Date
2022-05-09
Trial ID
NCT04400539
Treatments Being Tested
The goal of this observational study is to evaluate disease-free survival (...
Status
Unknown
Location
Sociedad de Lucha Contra el Cáncer
Start Date
2023-06-01
Trial ID
NCT05850377
This study is planned to detect a dose-efficacy relationship between the ch...
Status
Completed
Location
Multiple Locations
Start Date
2000-02
Trial ID
NCT02755142
Treatments Being Tested
The aim of the study is to examine the safety and feasibility of using 5-AL...
Status
Not Yet Recruiting
Location
Nottingham Children's Hospital
Start Date
2025-03-25
Trial ID
NCT06678867
Treatments Being Tested
The study pilot evaluate the feasibility of a "5-ALA- PpIX (protoporhyrin I...
Status
Completed
Location
Hôpital Roger Salengro, CHRU
Start Date
2017-05-05
Trial ID
NCT03048240
This is a phase I dose escalation study of photodynamic therapy (PDT) for t...
Status
Withdrawn
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2019-12-01
Trial ID
NCT02698293
Treatments Being Tested
In this multicenter, randomized, non-blinded trial the efficacy and safety ...
Status
Terminated
Location
Medizinische Fakultät Carl Gustav Carus, Klinik und Poliklinik für Neurochirurgie
Start Date
2021-04-12
Trial ID
NCT04469699
The purpose of this study is to determine the safety and utility of 5-amino...
Status
Withdrawn
Location
Emory University Hospital Midtown
Start Date
2015-11
Trial ID
NCT01445691
Treatments Being Tested
The investigational drug 5-ALA (known under the trade name Gliolan®) is an ...
Status
Recruiting
Location
University Hospital Münster, Klinik für Neurochirurgie
Start Date
2022-11-09
Trial ID
NCT05590689
Treatments Being Tested
Epilepsy is one of the most common neurological disorders, with one of the ...
Status
Not Yet Recruiting
Location
Hôpital Neurologique Pierre Wertheimer - Groupement Hospitalier Est - Hospices Civils de Lyon
Start Date
2026-09
Trial ID
NCT07657975
Treatments Being Tested